Spineart, a fast-growing company specialized in spine surgery, proudly announces the 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its SCARLET® AC-Ti secured anterior cervical cage.
The SCARLET® AC-Ti builds on a decade of experience with the SCARLET® system. The SCARLET® AC-Ti addition introduces new features such as the MIMETIX® morphometric profile, developed with digital models of the vertebrae to optimize the contact surface between implant and endplates. The system allows for fixation with screws and anchors.
The SCARLET® AC-Ti cervical cage utilizes Spineart’s proprietary Ti-LIFE technology1. Ti-LIFE technology, a proprietary additive manufacturing process, has a porous structure that closely mimics the trabecular bone structure.
“This approval underscores our commitment to innovation, continuously evolving our most successful products, such as the SCARLET® system,” said Alessia Erlingher, Chief Commercial Officer at Spineart.
Source: Company Press Release
